Polyacrylic acid-polyvinylpyrrolidone complex for achieving hemostasis after hemodialysis: study protocol for an...

Area of Science:

• Biomaterials Science
• Nephrology
• Vascular Access Management

Background:

• Effective hemostasis at vascular access sites is crucial for patients undergoing maintenance hemodialysis (HD).
• A novel polyacrylic acid-polyvinylpyrrolidone (PAA-PVP) complex has been developed, forming a hydrogel that adheres to the skin for hemostatic effect.
• This study evaluates its efficacy compared to traditional non-woven fabric pads.

Purpose of the Study:

• To compare the hemostatic efficacy of the PAA-PVP complex against conventional pads.
• To determine if the PAA-PVP complex can reduce the time required for hemostasis at the needle puncture vascular access site in HD patients.

Main Methods:

• An open-label, crossover, randomized controlled trial involving 50 HD patients.
• Participants were randomized to receive either the PAA-PVP complex or conventional pads.
• An adaptive '3+3' design was used to determine the minimum hemostasis time, with escalating or maintaining time points based on success rates.

Main Results:

• The primary endpoint is the hemostasis time on the arterial side of the vascular access.
• Statistical analysis will utilize mixed-effect models for repeated measures.
• Results will indicate whether the PAA-PVP complex offers a significant reduction in hemostasis time.

Conclusions:

• The study is expected to provide evidence on the effectiveness of the PAA-PVP complex for vascular access hemostasis.
• Findings will inform clinical practice regarding improved hemostatic agents for hemodialysis patients.
• This research could lead to enhanced patient safety and treatment efficiency in HD settings.